Immunome leverages the information stored in memory B cells to guide our discovery of first-in-class antibody therapeutics directed at potentially novel targets.

Our Approach

Leverages broad and deep interrogation of “highly-educated” B cells from patients who have learned how to fight off their disease.
Enables the simultaneous discovery of novel antigens (targets) and the patient-derived, native antibodies that bind to those targets with high affinity.

Output from Immunome’s Discovery Engine is used to develop novel antibody-based therapeutics directed at areas of high unmet need, such as cancer and infectious diseases.